Business Wire

U.S. Ambassador Johnson and UK’s Sir Nicholas Soames to join Bermuda Premier at Executive Forum in London

Share

The United States Ambassador to the United Kingdom (UK), Robert Wood Johnson, and the UK’s Rt. Hon. Sir Nicholas Soames, former defence minister and former Conservative Member of Parliament for Mid Sussex, will join Bermuda’s Premier, the Hon. E. David Burt, JP, MP, at an Executive Forum in London this month to highlight the historic and successful economic relationship that exists between Bermuda, the U.S. and the UK.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005627/en/

Bermuda Executive Forum London 2019 opening panel. (Photo: Business Wire)

Bermuda Executive Forum London 2019 opening panel. (Photo: Business Wire)

The keynote conversation between Ambassador Johnson, Sir Nicholas Soames and the Premier will explore the implications of global trends, address key challenges from Brexit to U.S. tax reform, and shed light on new opportunities to further develop economic ties. The discussion will be moderated by Fiona Luck, a Non-Executive Director on the Lloyd’s of London Franchise Board, whose more than 30 years’ experience in insurance and reinsurance will bring valuable insights from Bermuda’s traditional powerhouse industry, a significant contributor to the world’s economy.

Under the theme ‘Navigating Disruption for Positive Change’, the Bermuda Executive Forum London takes place Tuesday, November 26 and is hosted by the Bermuda Business Development Agency (BDA). It will bring together government officials, regulators and industry leaders for a full-day agenda of engaging panel discussions and keynotes across a range of sectors including re/insurance, asset management, family offices, financial services and technology. A networking reception will close the event in the evening.

“We look forward to welcoming Ambassador Johnson and Sir Nicholas Soames to our forum in London. Their participation, alongside our Premier, will ensure a dynamic and informative start to the day,” said Roland Andy Burrows, CEO of the BDA. “The U.S. and the UK are highly valued Bermuda partners and we have long enjoyed robust, mutually beneficial relationships that continue to thrive in many areas. As world-leading and innovative financial centres there’s clearly a lot of common ground for collaboration where we can work together to grow business and investment for the benefit of all.”

Ambassador Johnson was nominated by President Trump on June 22, 2017. He made his first official visit to Bermuda in July this year when he spoke about the strength and long-term nature of Bermuda’s relationship with the U.S. and expressed his admiration for the island’s unique capabilities and world-class expertise.

A prominent businessman and philanthropist, Ambassador Johnson served for more than 30 years as the Chairman and CEO of The Johnson Company, a private asset management firm founded in 1978, and as the Chairman and CEO of the New York Jets football team and New York Jets Foundation. He is the Founding Chairman of the Lupus Research Alliance and worked for many years with the Juvenile Diabetes Research Foundation.

Former Conservative Party grandee and grandson of the great wartime leader Sir Winston Churchill, Sir Nicholas served until recently as the Member of Parliament for Mid Sussex. Prior to that, he was the UK Minister of State for the Armed Forces from 1994-1997. Having previously worked as a stockbroker and on the staff of a U.S. Senator in Washington D.C, he has specialist knowledge in the fields of Europe, defence, international affairs, aviation and trade and industry. He also has a longstanding involvement in the Insurance and Reinsurance business as a Senior Advisor to Marsh the Global Leader in Broking and Risk Management. In March earlier this year, Sir Nicholas met with Premier Burt as part of a wider Bermuda Government trip to the UK and Brussels.

Mr Burrows added, “Against a backdrop of global economic and digital disruption, our event provides a platform for an open dialogue on how best to embrace change to bring about positive transformations and future growth. It is an ideal opportunity to directly engage with partners in the UK market, to share knowledge and forge new connections with prospective businesses and investors who would benefit from Bermuda’s global connectivity combined with its quality, stability and ease of doing business.”

The BDA forum builds on a two-day event held in London last year opened by Premier Burt with more than 50 experts as speakers and panellists. The event attracted close to 200 delegates encompassing a wide range of industries, and featured the UK’s Chris Holmes, Lord of Richmond MBE, and Bermudian Chief Executive of American International Group (AIG), Brian Duperreault.

To register for the Bermuda Executive Forum London 2019, click here.

CONNECTING BUSINESS

The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.

Contact information

MEDIA CONTACT:
Nicola Stevens
Director of Communications and PR
nstevens@bda.bm
+1 441 292 7774

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

 OKEx To Launch Options Trading9.12.2019 09:30:00 CETPress release

OKEx, the world’s largest spot and futures digital asset exchange by trading volume, today announced the launch of options trading. Developed from the ground up, OKEx Options represents a complete upgrade to the platform’s trading architecture, backed by a faster, more stable and robust infrastructure. Options trading will be available on OKEx starting from December 27, 2019, and simulation will begin on December 12, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191209005034/en/ (Graphic: Business Wire) With this addition, OKEx is the first crypto exchange to offer C2C, spot, futures, perpetual swap, and options trading under the same roof. Users can select from a wide range of products to best fit their trading and hedging strategies. Options trading is a type of derivatives trading that gives the buyer the ability to purchase or sell an underlying asset after paying a premium. OKEx Options will offer both buy and wr

Sabio Group Strengthens Leadership to Support Accelerated Growth9.12.2019 09:00:00 CETPress release

Sabio Group has strengthened its leadership team to support the company’s goal of becoming a dominant player in the Customer Experience market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191209005053/en/ Jonathan Gale appointed as Sabio Group CEO (Photo: Business Wire) To further accelerate its core strategy, Jonathan Gale has been appointed as Sabio Group CEO where he will lead the ongoing development, communication and execution of a clear and compelling strategy for Sabio for the next stage of its journey. Jonathan brings over 30 years’ experience in the SaaS technology industry, 20 of which being focused on Customer Experience and Contact Centres. This knowledge, combined with a detailed understanding of the creation of cloud products and services, will help Sabio build on its existing platform of Contact Centre, Digital and Insight offerings. Jonathan’s background includes leading NewVoiceMedia as CEO from start-up

Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis9.12.2019 08:00:00 CETPress release

Galderma today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational therapy nemolizumab for the treatment of pruritus associated with prurigo nodularis. Prurigo nodularis is a rare, potentially debilitating, chronic skin condition with thick skin nodules covering large body areas and associated severe pruritus. It frequently leads to a severe quality of life impairment. Nemolizumab is a first-in-class investigational monoclonal antibody that blocks signaling of IL-31. Galderma recently presented, at the 28th Annual Congress of the European Academy of Dermatology and Venereology, the results of a Phase 2 study in adult patients with moderate-to-severe prurigo nodularis. Nemolizumab not only met the primary endpoint of a greater improvement in peak pruritus Numerical Rating Scale (PP NRS) from baseline compared to placebo, but also significantly improved skin lesions as measured by Investigator Global Assessment (I

Immunocore announces dosing of first patient with third ImmTAC® bispecific9.12.2019 07:06:00 CETPress release

Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announced the start of the first-in-human clinical trial of IMC-C103C, the third bispecific developed using the company’s innovative ImmTAC® technology platform. IMC-C103C is focused on targeting tumours that express the protein MAGE-A4 (Melanoma-Associated Antigen A4) and is being developed in partnership with Genentech, a member of the Roche Group. The trial (IMC-C103C-101) is designed to study the safety and preliminary activity of IMC-C103C as a monotherapy and in combination with atezolizumab (Tecentriq®) in patients with MAGE-A4-expressing cancers. David Berman, Head of Research and Development at Immunocore, commented: “We have now brought our third TCR- engineered bispecific ImmTAC into the clinic. IMC-C103C is designed to re-direct T cells to attack MAGE-A4 expressing tumours and we’re pleased to be moving its clinical development forward in partnership with Genentech.” - Ends - About Immunocore I

SAS (Scandinavian Airlines) Improves Customer Service and Cuts Costs with Scandit’s Barcode Scanning on Smartphones9.12.2019 07:00:00 CETPress release

Scandit, the leading enterprise technology platform for mobile computer vision and augmented reality (AR), today announced that SAS (Scandinavian Airlines System) has integrated its powerful scanning software into their new Ground Handling App for smartphones, to replace expensive built-in scanners and upgrade critical ground workflows. The mobile app (developed by Stockholm-based Objective Solutions) brings new efficiency and cost savings to workflows using mobile scanning of boarding passes, passports, meal vouchers and baggage tags. SAS has deployed the Scandit-powered app to their three Scandinavian airport hubs: Stockholm Arlanda, Oslo Gardermoen, and Copenhagen Kastrup. A detailed case study about the integration is now available. SAS carries more than 30 million passengers annually to 120 destinations on over 170 aircraft and is widely recognized as a pioneer in digital innovation for the air travel industry. The Ground Handling App is part of a global, digital infrastructure in

Verimatrix Completes Sale of its Silicon IP Business Unit to Rambus9.12.2019 06:30:00 CETPress release

Regulatory News: Verimatrix (Euronext Paris: VMX), formerly known as Inside Secure, a global provider of security and analytics solutions that protect devices, services and applications, today announced the completion of the sale of its Silicon IP and Secure Protocols business unit to Rambus Inc. (NASDAQ: RMBS) for a total cash consideration of $65 million including an earn-out. Verimatrix received an amount of $45m at closing and could receive an additional amount of up to $20 million, subject to completion of certain revenue targets for the transferred business for the calendar year 2020. This transaction increases Verimatrix’ focus as a pure player in software-based security and business intelligence solutions, while substantially improving the company’s financial flexibility thanks to a strengthened balance-sheet. At completion of the transaction, Verimatrix’s net debt1 is estimated at $17.5 million and $(2.5) million in case the earn out is achieved in full (compared with net debt